News 2005

Crionna Competes Successfully with Global CRO to Win US Phase III Oncology Trial

 21 February Crionna, has been selected by a US Biotech to manage their European Phase III Oncology study in Oral Cancer. Crionna competed successfully against a leading global CRO to win the contract for the study. The study is expected to run for over two years in 25 centres in Europe and will utilise Crionna’s extensive network of contacts at major European Oncology centres. The study will capitalise on Crionna's demonstrated ability to identify international sites of high patient recruitment. FDA approval is expected within the next two months.


Crionna Awarded UK Innovation Grant to Develop Novel Electronic Data Capture System

13 March The Crionna Data Management team are delighted at reaching the first stage of development of specialised tools to improve clinical trial quality and timelines. Scottish Enterprise have today awarded the company a Small Company Innovation Scheme grant to help develop TARDICE, a hand held data collection system for doctors running clinical trials. This system will improve the speed of collection and the quality of data input allowing clincians to spend more time with their patients.

 Crionna have teamed up with BEAT systems an innovative IT company to develop the software for TARDICE. BEAT has a proven track record in developing this system for the police and other security companies where high speed remote data entry has recently been demonstrated to improve efficiency and reduce manpower requirements.

Crionna Launches 200 patient Study to Validate TARDICE

15 June Crionna enlisted the help of surgeons in Birmingham to test TARDICE in it's first clinical trial. It is hoped that the process of data collection from over 200 patients will be improved using the advanced electronic data capture tool. This study will provide a unique and valuable insight into the comparative advantages and disadvantages of both paper and electronic form completion. Data will be uploaded directly into a data base without the need for transcription. Physicians are enthusiastic about the potential time savings and portability of the system.

Crionna Win Contract from Major US Medical Devices company to Validate 3D imaging systems in Clinical Trials

20 August Crionna have signed a contract with a leading US company to compare two 3D imaging systems against MRI in a pilot clinical trial. If successful the imaging systems could provide an easier and more patient friendly alternative to MRI in the measurement of contour changes.